ACLARIS THERAPEUTICS INC (ACRS)
US00461U1051 - Common Stock
ACLARIS THERAPEUTICS INC
NASDAQ:ACRS (11/20/2024, 8:05:06 PM)
After market: 3.87 -0.09 (-2.27%)3.96
-0.63 (-13.73%)
Company Profile
Aclaris Therapeutics, Inc. operates as a dermatologist-led biopharmaceutical company, which engages in identifying, developing, and commercializing novel drugs to address the needs in medical and aesthetic dermatology and immunology. The company is headquartered in Wayne, Pennsylvania and currently employs 91 full-time employees. The company went IPO on 2015-10-07. The firm has a multi-stage portfolio of drug candidates powered by a robust research and development engine exploring protein kinase regulation. Its segments include therapeutics and contract research. The therapeutics segment is focused on identifying and developing therapies to address unmet needs for immuno-inflammatory diseases and providing licensing of its intellectual property. The contract research segment provides laboratory services. The firm's KINect drug discovery platform combined with its preclinical development capabilities allows it to identify and advance potential drug candidates that it may develop independently or in collaboration with third parties. The firm's drug candidates include ATI-1777, ATI-2138 and Zunsemetinib. ATI-1777 is an investigational topical soft Janus kinase, or JAK, 1/3 inhibitor.
Company Info
ACLARIS THERAPEUTICS INC
701 Lee Road, Suite 103
Wayne PENNSYLVANIA 19087
P: 14843247933
CEO: Neal Walker
Employees: 91
Website: https://www.aclaristx.com/
ACRS News
12 hours ago - ChartmillOn Wednesday, there are stocks with unusual volume. Let's take a look.Which stocks have an unusual volume on Wednesday?
a day ago - ChartmillHere are the top movers in Tuesday's session, showcasing the stocks with significant price changes.Intrigued by the market activity one hour before the close of the markets on Tuesday? Uncover the key winners and losers of today's session in our insightful analysis.
2 days ago - ChartmillThese stocks are moving in today's sessionHere are the top movers in Tuesday's session, showcasing the stocks with significant price changes.
2 days ago - ChartmillThe market is buzzing with gapping stocks on Tuesday. Let's uncover which stocks are experiencing notable gaps during today's session.The session on Tuesday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.
2 days ago - ChartmillTop movers in Tuesday's pre-market sessionPre-market stock analysis on 2024-11-19: top gainers and losers in today's session.
3 days ago - Biosion, Inc.Biosion Announces Exclusive, Global License Agreement with Aclaris Therapeutics on two potential First-in-Class and Best-in-Class Immunology AssetsBiosion receives over $40 million cash payment as upfront license fee and reimbursement for certain development costs & drug product materials, and 19.9%...
ACRS Twits
Here you can normally see the latest stock twits on ACRS, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
